Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BIORA THERAPEUTICS, INC. (PROG)
|
|
| Cash Flow Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Net income | -17.8 | -17.4 | -5.1 | -5.5 | -13.8 | -92.9 | -43.7 | -78.5 |
| Depreciation and amortization | 0.2 | 0.1 | 0.2 | 0.2 | 0.3 | 0.4 | 0.1 | 0.5 |
| Change in working capital [+] | 3.1 | 3.1 | 4.5 | -0.3 | -2.3 | -7.6 | -4.4 | 7.1 |
| Accrued expenses | 3.1 | 3.1 | 4.4 | -0.8 | -3.7 | -25.6 | -4.4 | 6.5 |
| Other | | | 0.1 | 0.5 | 1.4 | 17.9 | | 0.6 |
| Other operating activities | 2.9 | 2.1 | -9.5 | -14.5 | -9.5 | 53.5 | 6.5 | 52.6 |
| Cash from operations | -11.6 | -12.1 | -9.9 | -20.1 | -25.3 | -46.7 | -41.5 | -18.3 |
| |
| Capital expenditures | 0.0 | 0.0 | 0.2 | 0.2 | 0.3 | 0.0 | 0.0 | 0.4 |
| Purchases of property and equipment | 0.0 | 0.0 | 0.2 | 0.2 | 0.3 | | 0.0 | 0.4 |
| Other cash from investing | 0.0 | 0.0 | -0.3 | -0.4 | -0.7 | 0.2 | -0.4 | -1.0 |
| Cash from investing | 0.0 | 0.0 | -0.2 | -0.2 | -0.3 | 0.2 | -0.4 | -0.6 |
| |
| Issuance of common stock, net | | 12.9 | 1.7 | 1.2 | 3.6 | 23.4 | 0.0 | 11.7 |
| Other cash from financing | 7.6 | -0.8 | -3.1 | 0.0 | -0.5 | 50.2 | 31.7 | 25.8 |
| Cash from financing | 7.6 | 12.1 | -1.5 | 1.1 | 3.1 | 73.5 | 31.8 | 37.5 |
| |
| Free cash flow | -11.6 | -12.1 | -9.7 | -19.9 | -24.9 | -46.7 | -41.5 | -17.9 |
| Per share (diluted) | ($0.96) | ($1.10) | ($0.05) | ($2.70) | ($3.40) | ($0.49) | ($0.43) | ($0.28) |
| |
| Cash paid for interest | 1.1 | | | 4.8 | | 5.2 | -0.7 | 3.0 |
| Cash paid for income taxes | 0.0 | | 0.0 | 0.0 | 0.0 | | 0.3 | 0.0 |
|